Acute Porphyria Drug Database

Monograph

A16AX03 - Sodium Phenylbutyrate
Propably not porphyrinogenic
PNP

Rationale
Sodium phenylbutyrate does not affect the activity of cytochrome P450 enzymes.
Metabolism and pharmacokinetics
Similar drugs
Explore alternative drugs in similar therapeutic classes A16A / A16AX or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Ammonaps 500 mg tabletten · Ammonaps 940 mg/g granulaat · PHEBURANE 350 mg/ml orale oplossing · Pheburane 483 mg/g, granulaat Ammonaps 500 mg comp. · Ammonaps 940 mg/g gran. · Pheburane 350 mg/ml sol. buv. · Pheburane 483 mg/g gran. Ammonaps · Ammonaps 940 mg/g Granulado · Pheburane · Pheburane 483 mg/g Granulado Pheburane AMMONAPS 500mg · AMMONAPS 940mg/g Ammonaps · Pheburane · Sodium phenylbutyrate Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙